More on CTL019, NVS’ “CAR-T” therapy… NVS PR: http://finance.yahoo.com/news/novartis-highlights-research-investigational-personalized-141400671.html Bloomberg: http://www.bloomberg.com/news/2013-12-07/designer-immune-cells-diminish-cancer-in-leukemia-cases.html NCI synopsis: http://www.cancer.gov/cancertopics/research-updates/2013/CAR-T-Cells